SECUKINUMAB

160421 reported adverse events

Drug classes: Interleukin-17A Antagonist [EPC]

These side effects are most commonly reported by patients taking SECUKINUMAB:

# Side effect Count
0 DRUG INEFFECTIVE 29187
1 PSORIASIS 22826
2 PAIN 16628
3 ARTHRALGIA 14911
4 FATIGUE 10590
5 PSORIATIC ARTHROPATHY 10208
6 MALAISE 9466
7 PRURITUS 9443
8 RASH 9122
9 CONDITION AGGRAVATED 8527
See all common reactions for SECUKINUMAB

SECUKINUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 REBOUND PSORIASIS 389 0.6707
1 HEPATIC ENZYME 91 0.6594
2 C-REACTIVE PROTEIN 582 0.6496
3 GRIP STRENGTH 147 0.6419
4 FACET JOINT SYNDROME 1958 0.6290
5 DEEP VEIN THROMBOSIS POSTOPERATIVE 1207 0.6235
6 LUPUS VULGARIS 726 0.6179
7 RHEUMATIC FEVER 2562 0.5942
8 SWOLLEN JOINT COUNT INCREASED 1749 0.5680
9 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 365 0.5539
See all enriched reactions for SECUKINUMAB